Coloplast A/S logo

Coloplast A/S - Class B

LTS:0QBO (Denmark)   Class B
kr 848.60 (0%) May 20
37.93
P/B:
11.81
Market Cap:
kr 191.28B ($ 27.83B)
Enterprise V:
kr 214.90B ($ 31.27B)
Volume:
-
Avg Vol (2M):
45.63K
Also Trade In:
Volume:
-
Avg Vol (2M):
45.63K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Coloplast A/S ( ) from 2007 to May 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Coloplast A/S stock (LTS:0QBO) PE ratio as of May 21 2024 is 37.93. More Details

Coloplast A/S (LTS:0QBO) PE Ratio (TTM) Chart

To

Coloplast A/S (LTS:0QBO) PE Ratio (TTM) Historical Data

Total 1267
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Coloplast A/S PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-21 37.9 2024-03-15 42.4
2024-05-20 37.9 2024-03-14 42.1
2024-05-17 37.9 2024-03-13 43.3
2024-05-16 37.5 2024-03-12 43.5
2024-05-15 37.3 2024-03-11 43.3
2024-05-14 37.2 2024-03-08 43.5
2024-05-13 37.5 2024-03-07 42.9
2024-05-10 37.8 2024-03-06 42.2
2024-05-09 37.8 2024-03-05 41.7
2024-05-08 37.8 2024-03-04 41.8
2024-05-07 37.4 2024-03-01 41.0
2024-05-03 38.4 2024-02-29 41.1
2024-05-02 37.7 2024-02-28 40.5
2024-05-01 37.4 2024-02-27 40.9
2024-04-30 38.0 2024-02-26 41.0
2024-04-29 38.7 2024-02-23 41.0
2024-04-26 38.5 2024-02-22 40.3
2024-04-25 38.6 2024-02-21 39.8
2024-04-24 41.1 2024-02-20 39.6
2024-04-23 40.8 2024-02-19 39.8
2024-04-22 40.0 2024-02-16 39.9
2024-04-19 40.4 2024-02-15 40.0
2024-04-18 40.5 2024-02-14 39.5
2024-04-17 40.4 2024-02-13 38.4
2024-04-16 41.0 2024-02-12 39.3
2024-04-15 41.0 2024-02-09 40.1
2024-04-12 40.6 2024-02-08 36.4
2024-04-11 41.6 2024-02-07 36.4
2024-04-10 41.0 2024-02-06 35.8
2024-04-09 40.8 2024-02-05 35.6
2024-04-08 40.6 2024-02-02 35.6
2024-04-05 40.8 2024-02-01 35.6
2024-04-04 41.3 2024-01-31 35.5
2024-04-03 41.2 2024-01-30 35.2
2024-04-02 40.8 2024-01-29 34.5
2024-03-29 41.4 2024-01-26 34.5
2024-03-28 41.4 2024-01-25 34.5
2024-03-27 41.7 2024-01-24 34.7
2024-03-26 41.8 2024-01-23 35.0
2024-03-25 41.8 2024-01-22 35.2
2024-03-22 41.7 2024-01-19 35.3
2024-03-21 41.7 2024-01-18 35.3
2024-03-20 42.2 2024-01-17 36.0
2024-03-19 41.3 2024-01-16 35.2
2024-03-18 41.7 2024-01-15 36.0

Coloplast A/S (LTS:0QBO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.